Rate My Professor Shirley Jones

Shirley Jones serves as a Clinical Research Nurse in the Department of Paediatrics and Child Health (Dunedin) within the Faculty of Medicine at the University of Otago. Holding qualifications as an Enrolled Nurse (EN), she is actively involved in the Diabetes and Endocrinology Research Group, contributing to efforts aimed at improving health outcomes for individuals living with diabetes. Her research emphasizes advancements in diabetes technologies, particularly for children and young people, including access and utilization of new tools, factors influencing glycaemic control, and studies on vitamin D and bone health across pregnancy, lactation, and infancy. Multiple clinical trials are currently underway in these domains.

Jones has co-authored numerous publications in peer-reviewed journals, demonstrating her impact in the field of paediatric endocrinology and diabetes management. Key works include: "Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: The ACCESS-AID study protocol" (Journal of Diabetes & Metabolic Disorders, 2026); "First in human feasibility study: Automated insulin delivery utilizing a self-adapting algorithm in adults with Type 1 and Type 2 diabetes" (Journal of Diabetes Science & Technology, 2025); "Impact of automated insulin delivery on subjective and objective sleep in children and young adults with very high HbA1c: Sleep outcomes from the CO-PILOT randomised controlled trial" (Diabetic Medicine, 2025); "Impact of Simplera Sync™ sensors and Extended™ Wear Infusion Sets on glycaemia and system performance of the MiniMed™ 780G system in children and young adults with previously high HbA1c" (Diabetic Medicine, 2025); and "Use of a decision support tool and quick start onboarding tool in individuals with type 1 diabetes using advanced automated insulin delivery: A single-arm multi-phase intervention study" (BMC Endocrine Disorders, 2024). Additional contributions include studies on user experiences during the transition to calibration-free sensors (Frontiers in Endocrinology, 2023) and the effects of DIY continuous glucose monitoring (Journal of Diabetes and Metabolic Disorders, 2020).